PEBC Part I (MCQ) study materials
PEBC Part I (MCQ) study resources

PEBC Part I (MCQ): Drug Distribution, Dispensing and Medication Safety/Quality Assurance

PEBC Part I (MCQ) · Work through your exam, one topic at a time.

All guide sections

Drug Distribution, Dispensing and Medication Safety/Quality Assurance

What this domain tests

This domain covers the medication-use system: prescription screening, dispensing accuracy, product selection, labeling and counseling, inventory and recalls, storage, narcotic control, sterile and non-sterile compounding, automation, incident reporting, and quality assurance. The exam tests whether you can catch an error before it reaches the patient and whether you understand system fixes rather than blame.

Core rules

  • Screen every prescription for patient, drug, dose, route, frequency, duration, indication, allergies, interactions, renal/hepatic function, and therapeutic duplication.
  • Look-alike/sound-alike (LASA) drugs (e.g., hydrALAZINE/hydrOXYzine, glipiZIDE/glyBURIDE) require tall-man lettering, separated storage, and independent verification.
  • High-alert medications (insulin, opioids, anticoagulants, concentrated electrolytes, chemotherapy) need independent double checks, standardized concentrations, and clear labeling.
  • Dispensing is a series of verifiable steps: data entry, product selection, counting/preparation, label check, final pharmacist verification, and patient counseling.
  • Incident reporting should be non-punitive and focused on system causes: look at workflow, staffing, lighting, packaging, and technology.
  • Recalls and expiry dates: remove affected stock, document, notify patients when necessary, and follow the manufacturer's instructions.

Worked example

A handwritten prescription reads "hydralazine 50 mg PO BID." The handwriting is ambiguous and could be hydroxyzine. Do not guess. Check the patient's history and indication; call the prescriber, read back the order, and document the clarification. If hydralazine is confirmed, counsel on lupus-like symptoms, headache, and reflex tachycardia. If hydroxyzine is confirmed, counsel on sedation and anticholinergic effects. The key is that the ambiguity was resolved before dispensing, not after the patient received the wrong drug.

Traps

Do not assume legibility or "the prescriber always means X"; do not store LASA drugs side by side; do not skip the final check when busy; do not treat an incident as an individual's moral failing; do not dispense a recalled product because it is already on the shelf; do not counsel by asking "any questions?" only.